Hyperion Therapeutics to Present at the Leerink Swann Global Healthcare Conference

Hyperion Therapeutics to Present at the Leerink Swann Global Healthcare
Conference

SOUTH SAN FRANCISCO, Calif., Feb. 8, 2013 (GLOBE NEWSWIRE) -- Hyperion
Therapeutics (Nasdaq:HPTX) announced today that the company is scheduled to
present at the Leerink Swann Global Healthcare Conference on Thursday,
February 14 at 3:00 p.m. ET (12:00 p.m. PT).

Donald J. Santel, Chief Executive Officer of Hyperion, will provide a company
overview. To access the live webcast and subsequent archived recording, please
visit Hyperion's website at http://investors.hyperiontx.com/events.cfm.

About Hyperion Therapeutics

Hyperion Therapeutics, Inc. is a commercial stage biopharmaceutical company
committed to developing and delivering life-changing treatments for orphan
diseases and hepatology. For more information, please visit www.hyperiontx.com

CONTACT: Shari Annes, Investor Relations
         (650) 888-0902
         sannes@annesassociates.com
        
         Kristie Kuhl, Media Relations
         (203) 556-7417
         kkuhl@makovsky.com
 
Press spacebar to pause and continue. Press esc to stop.